← All trials
NCT04773301
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 13, 2021
- Primary completion
- Sep 30, 2021
- Completion date
- Oct 31, 2021
- First posted
- Feb 26, 2021
- Last posted
- Mar 3, 2021
- Enrollment
- 108
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Instituto de Estudios de Ciencias de la Salud de Castilla y León (IECSCYL)Lead sponsor
- University of SalamancaOverall official - principal investigator
- University of SalamancaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.